DexCom Outlines Growth Plan and Shareholder-Friendly Measures

DexCom (DXCM) shares rose as the company announced a long-term growth strategy through 2030, including at least 10% annual revenue growth targets. The firm also authorized a $1 billion share buyback program and highlighted next-generation product developments.

By 35 minutes ago | marketbeat.com · Auto-Fetched Original Sources · May 16, 2026, 13:07 UTC

Tickers: $DXCM

Topics: board changes DexCom growth strategy investor day share buyback

Read the full article at Auto-Fetched Original Sources

More World news

Nvidia Shares Plunge Following Announcement of CEO Jensen Huang's Resignation Seeking Alpha · November 12, 2026, 14:24 UTC
Archer Aviation Enters Multi-Year Partnership with Formula One Seeking Alpha · November 12, 2026, 14:16 UTC
Edgewell Personal Care Announces Quarterly Dividend of $0.15 Per Share Seeking Alpha · November 12, 2026, 14:16 UTC
Hudbay Minerals Announces Quarterly Dividend of CAD 0.01 Per Share Seeking Alpha · November 12, 2026, 14:16 UTC
Warby Parker Unveils AI-Powered Intelligent Eyewear Collection in Partnership with Google and Samsung Seeking Alpha · November 12, 2026, 14:17 UTC
Where Food Comes From Reports Q3 Revenue Growth and Improved Gross Margins Seeking Alpha · November 12, 2026, 14:17 UTC
Medical Care Technologies Inc. Reports Q3 Revenue Growth and Significant Net Income Increase Seeking Alpha · November 12, 2026, 14:17 UTC
Digi International Reports Record Fiscal 2026 Results and Announces Acquisition of Disruptive Technologies Motley Fool · November 12, 2026, 14:15 UTC
U.S. Trade Representative Jamieson Greer to Discuss Tariff Policies and Export Controls CNBC · November 12, 2026, 13:31 UTC
Coinbase CEO Brian Armstrong Discusses Binance Hack and Political Shifts Impacting Crypto CNBC · November 12, 2026, 13:44 UTC